Helix (Injective) vs Paradex Helix (Injective) leads by 28 points.
Helix (Injective) scores 28 points above Paradex on the published criteria (24.4 vs 13.4 points), which this ranking scores from the record as a whole, not criterion by criterion. Helix (Injective) ranks #2 and Paradex #8 of 12 published perp DEXs. Every term of the gap is on the ledger below; the inputs are on the audit receipt.
Helix (Injective)77
vs
PAParadex49
Scores are out of 100; published scores fall within 41–99 · ranks #2 and #8 of 12
Helix (Injective) scores 28 points above Paradex on the published criteria (24.4 vs 13.4 points), which this ranking scores from the record as a whole, not criterion by criterion.
Helix (Injective) #2 of 1277
PAParadex #8 of 1249
Scores are out of 100; published scores fall within 41–99; a bar is empty at 41 and full at 99.
Why, term by termHelix (Injective) leads on 0 of 2 published criteria; Paradex on 0. The terms sum to the gap.
TermHelix (Injective)ParadexWeightPoints
Published criteriaScore dimension24.413.430+28.6for Helix (Injective)
Net of the terms+28.6
Reproduced gap+28.6
Published gapAfter score rounding and bounds — see the note below7749+28.0
Weight is in points of the 86-point weighted total. Points are score points of the gap between the two.
This ranking scores its published criteria from the record as a whole, not criterion by criterion, so they count here as one term and no single criterion is credited.
Helix (Injective)Score 77Fully onchain orderbook on Injective — no offchain matchingStrength: Fully onchain orderbook — no offchain matchingWatch-out: Trust base is the Injective validator set / governance-upgradeable chain modulesParadexScore 49Starknet appchain perps — offchain order matching, bridged custodyStrength: Starknet-based appchain with settlement proven onchainWatch-out: A January-2026 chain rollback reversed an incident — an operational intervention and a centralisation/liveness signal to weigh
Quick facts
At a glance
2 of 5 rows read the same for both.
FactHelix (Injective)Paradex
Trading feeSnapshotModel: fully onchain orderbook (Injective exchange module). Since 2022. Self-custodial. INJ governance. Audited. Up to ~100x. Fees (Helix docs "Fees & Rebates", read 3 November 2026): "Taker Fee": "0.05%", "Maker Fee": "-0.005%", with VIP discounts for staked INJ and volume. Live TVL shown for context, not scored.Model: offchain orderbook on a Starknet-based appchain (centralized sequencer matching, settlement proven onchain). Since 2024. Bridged custody; admin-controlled (the operator can block L1 deposits and limit L1 and L2 withdrawals). Audited (Cairo Security Clan, May 2025). Jan-2026 chain rollback (operational, not a fund-draining exploit). Up to 50x. Fees (Paradex docs "Trading Fees", read 3 November 2026): "Retail Takers and Makers have 0% fees on all products: Perps, Spot and Options"; API (Pro) traders pay the published Pro schedule. Live TVL shown for context, not scored.
Helix (Injective) leads on no published criterion; its edge is published criteria (24.4 vs 13.4 points). Pick it if that term is what you are buying.
Strength
Fully onchain orderbook — no offchain matching
Tradeoff
Trust base is the Injective validator set / governance-upgradeable chain modules
PA
Paradex
49#8 of 12
Pick it when
Paradex leads Helix (Injective) on no published criterion and no score dimension — pick it only if a fact outside the score (country, funding rail, custody) decides for you.
Strength
Starknet-based appchain with settlement proven onchain
Tradeoff
A January-2026 chain rollback reversed an incident — an operational intervention and a centralisation/liveness signal to weigh
Self-identify in 10 seconds
Which one is actually for you?
Helix (Injective)Leads
Helix (Injective) leads Paradex on no published criterion
Choose it only if something outside the published criteria decides for you — your country, a funding rail, or custody.
Helix (Injective)Score 77Fully onchain orderbook on Injective — no offchain matchingStrength: Fully onchain orderbook — no offchain matchingWatch-out: Trust base is the Injective validator set / governance-upgradeable chain modules
PAParadex
Paradex leads Helix (Injective) on no published criterion
Choose it only if something outside the published criteria decides for you — your country, a funding rail, or custody.
ParadexScore 49Starknet appchain perps — offchain order matching, bridged custodyStrength: Starknet-based appchain with settlement proven onchainWatch-out: A January-2026 chain rollback reversed an incident — an operational intervention and a centralisation/liveness signal to weigh
Criterion by criterion
Scorecard
Published criteria · weight in points of 860 of 4 cells scored. Strength is read from the evidence file; the weight is the published one. Methodology
Security
weight 14.4 of 86Not scored
Helix (Injective)Not scored
No evidence cell for this criterion, so no strength is drawn.
ParadexNot scored
No evidence cell for this criterion, so no strength is drawn.
Decentralization
weight 9.6 of 86Not scored
Helix (Injective)Not scored
No evidence cell for this criterion, so no strength is drawn.
ParadexNot scored
No evidence cell for this criterion, so no strength is drawn.
Score dimensions
weights sum to 86
The published score is five dimensions, each weighted for the category. "Published criteria" is the criteria block above; the other four are the engine's own terms — availability, friction, trust record, measured data. Each bar is one side's points out of that dimension's maximum; the weight beside the name is its points of the 86-point weighted total. The published criteria above can fill 24 of the block’s 30. A weight marked “constant here” belongs to a dimension every ranked product in the category holds at the same value: it still counts in the total, and it orders nothing here.
Availabilityweight 20 of 86 · constant here
Helix (Injective)14/20Paradex14/20
Tie
Published criteriaweight 30 of 86
Helix (Injective)24.4/30Paradex13.4/30
Helix (Injective) leads
Frictionweight 10 of 86 · constant here
Helix (Injective)2.7/10Paradex2.7/10
Tie
Trust recordweight 8 of 86 · constant here
Helix (Injective)3.2/8Paradex3.2/8
Tie
Measured dataweight 18 of 86 · constant here
Helix (Injective)5.5/18Paradex5.5/18
Tie
Decision rulePublished order
Choose Helix (Injective) unless the term Paradex leads on is the one you are buying.
Paradex leads Helix (Injective) on no published criterion and no score dimension — pick it only if a fact outside the score (country, funding rail, custody) decides for you.
The published order weighs every criterion the same way for everyone. To weigh them your way, run .
From the published order
Next best action
If this isn't your case
Other matchups worth comparing
How you can lose money here, and what the ranking scores
Contract failure: the code holding the funds is exploited.
Scored by Security & track record · 60%
Control failure: a key or vote changes the rules, freezes or mints.
Scored by Decentralization & trust-minimization · 40%
Not assessed by this ranking: Oracle failure, Insolvency failure, Regulatory failure, Execution failure, Exit failure. A high place says nothing about these; the Methodology tab says what each means.
Questions
Frequently asked questions
Helix (Injective) scores 28 points above Paradex on the published criteria (24.4 vs 13.4 points), which this ranking scores from the record as a whole, not criterion by criterion. Published scores, out of 100: Helix (Injective) 77 (rank 2 of 12 perp dexs), Paradex 49 (rank 8 of 12).
Reviewed means both products compared here was read against its sources on or after that date; every ranked category is re-read at least every 45 days. Models research, extract and parse. A deterministic engine ranks. Every quote passes an adversarial refute pass.
Answer a few quick questions and get one clear recommendation based on how you actually plan to use crypto — with rationale, tradeoffs, and a path to monitor the decision.
No signup·Free first pass · Private·No spam · No account
Not financial advice · Independent · Always do your own research
Not financial advice · For informational purposes only · Always do your own research
